Block GA - Search Results

1

Re-evaluation of risks associated with hyperphosphatemia and hyperparathyroidism in dialysis patients: recommendations for a change in management.

Block GA, Port FK. Block GA, et al. Am J Kidney Dis. 2000 Jun;35(6):1226-37. doi: 10.1016/s0272-6386(00)70064-3. Am J Kidney Dis. 2000. PMID: 10845841 Review.

2

Control of serum phosphorus: implications for coronary artery calcification and calcific uremic arteriolopathy (calciphylaxis).

Block GA. Block GA. Curr Opin Nephrol Hypertens. 2001 Nov;10(6):741-7. doi: 10.1097/00041552-200111000-00003. Curr Opin Nephrol Hypertens. 2001. PMID: 11706300 Review.

3

Mortality effect of coronary calcification and phosphate binder choice in incident hemodialysis patients.

Block GA, Raggi P, Bellasi A, Kooienga L, Spiegel DM. Block GA, et al. Kidney Int. 2007 Mar;71(5):438-41. doi: 10.1038/sj.ki.5002059. Epub 2007 Jan 3. Kidney Int. 2007. PMID: 17200680 Clinical Trial.

4

Correlation of simple imaging tests and coronary artery calcium measured by computed tomography in hemodialysis patients.

Bellasi A, Ferramosca E, Muntner P, Ratti C, Wildman RP, Block GA, Raggi P. Bellasi A, et al. Among authors: block ga. Kidney Int. 2006 Nov;70(9):1623-8. doi: 10.1038/sj.ki.5001820. Epub 2006 Sep 6. Kidney Int. 2006. PMID: 16955104 Clinical Trial.

5

Prevalence and clinical consequences of elevated Ca x P product in hemodialysis patients.

Block GA. Block GA. Clin Nephrol. 2000 Oct;54(4):318-24. Clin Nephrol. 2000. PMID: 11076108 Review.

6

Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: a national study.

Block GA, Hulbert-Shearon TE, Levin NW, Port FK. Block GA, et al. Am J Kidney Dis. 1998 Apr;31(4):607-17. doi: 10.1053/ajkd.1998.v31.pm9531176. Am J Kidney Dis. 1998. PMID: 9531176

7

Association of pulse wave velocity with vascular and valvular calcification in hemodialysis patients.

Raggi P, Bellasi A, Ferramosca E, Islam T, Muntner P, Block GA. Raggi P, et al. Among authors: block ga. Kidney Int. 2007 Apr;71(8):802-7. doi: 10.1038/sj.ki.5002164. Epub 2007 Feb 21. Kidney Int. 2007. PMID: 17311068

8

Changes in secondary hyperparathyroidism-related biochemical parameters and medication use following parathyroidectomy.

Wetmore JB, Liu J, Do TP, Lowe KA, Ishani A, Bradbury BD, Block GA, Collins AJ. Wetmore JB, et al. Among authors: block ga. Nephrol Dial Transplant. 2016 Jan;31(1):103-11. doi: 10.1093/ndt/gfv291. Epub 2015 Aug 19. Nephrol Dial Transplant. 2016. PMID: 26292694

9

Refining the definition of clinically important mineral and bone disorder in hemodialysis patients.

Danese MD, Halperin M, Lowe KA, Bradbury BD, Do TP, Block GA. Danese MD, et al. Among authors: block ga. Nephrol Dial Transplant. 2015 Aug;30(8):1336-44. doi: 10.1093/ndt/gfv034. Epub 2015 Mar 27. Nephrol Dial Transplant. 2015. PMID: 25817224 Free PMC article.

10

Effects of phosphate binders in moderate CKD.

Block GA, Wheeler DC, Persky MS, Kestenbaum B, Ketteler M, Spiegel DM, Allison MA, Asplin J, Smits G, Hoofnagle AN, Kooienga L, Thadhani R, Mannstadt M, Wolf M, Chertow GM. Block GA, et al. J Am Soc Nephrol. 2012 Aug;23(8):1407-15. doi: 10.1681/ASN.2012030223. Epub 2012 Jul 19. J Am Soc Nephrol. 2012. PMID: 22822075 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results